TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive First Test Of Cooperative Groups’ Willingness To Change Coming In New Colorectal Trials November 14, 1986
TCL Archive NCAB Votes to Bring Organ Systems Coordinating Center Into NCI, Disperse Entire Grants Portfolio February 12, 1988